Flexion Therapeutics to Present at the 2017 Wells Fargo Healthcare Conference
August 30 2017 - 7:30AM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that
Michael Clayman, M.D., President and Chief Executive Officer, will
participate in an analyst-led fireside chat at the 2017 Wells Fargo
Healthcare Conference on Wednesday, September 6, 2017 at 9:40am ET
at the Westin Waterfront Hotel in Boston, Mass.
To access the live webcast and subsequent archived recording of
the presentation, please visit the Flexion website at
http://flexiontherapeutics.com/.
About Flexion Therapeutics Flexion Therapeutics
(Nasdaq:FLXN) is a specialty pharmaceutical company focused on the
development and commercialization of novel, local therapies for the
treatment of patients with musculoskeletal conditions, beginning
with OA, a type of degenerative arthritis. The company’s core
values are focus, ingenuity, tenacity, transparency and fun.
Flexion was named one of the Boston Business
Journal's 2017 Best Places to Work.
Contact:
Scott Young
Sr. Director, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Apr 2023 to Apr 2024